This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Vasculitis

Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis

Sponsored by University Hospital, Tours

About this trial

Last updated 3 years ago

Study ID

DR220193-BIOVAS

Status

Recruiting

Type

Observational

Placebo

No

Accepting

18-75 Years
16+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 2 years ago

What is this trial about?

To date, there are no reliable diagnostic blood markers of adult vasculitis. To date, the diagnosis of vasculitis is based on invasive procedure, biopsy of affected tissues potentially at risk of complication . In addition, there are no reliable biomarkers to predict the evolution of vasculitis (relapse, refractory form ...) necessary for the management of patients (type of treatment, duration ..) Prospective study, monocentric (CHU de Tours), non-interventional, aimed at finding diagnostic and prognostic biomarkers (both metabolomic and immunologic) in adult vasculitis patients.

What are the participation requirements?

Yes

Inclusion Criteria

- Age > 16 years

- Active vasculitis, new diagnosis or relapse

- IgA vasculitis

- ANCA vasculitis

- Giant cell arteritis

No

Exclusion Criteria

- Person who has objected to the processing of data

- Pregnant woman

- Patient positive for HIV, HBV, HCV

- Treatment in the previous month with corticosteroids, immunosuppressive drugs or biotherapy.

- Patient unable to understand the information leaflet

- Adult under guardianship or curatorship

Locations

Location

Status

Recruiting